Global X Genomics & Biotechnology ETF
GNOM
64 hedge funds and large institutions have $138M invested in Global X Genomics & Biotechnology ETF in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 10 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 15
14% more capital invested
Capital invested by funds: $121M → $138M (+$17.4M)
0.95% more ownership
Funds ownership: 15.88% → 16.84% (+0.95%)
2% less funds holding
Funds holding: 65 → 64 (-1)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$10M |
| 2 |
PFG
Prosperity Financial Group
San Ramon,
California
|
+$2.02M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$795K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$424K |
| 5 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
+$302K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIG
McGuire Investment Group
Wakefield,
Rhode Island
|
-$2.03M |
| 2 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$1.64M |
| 3 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$748K |
| 4 |
Nomura Asset Management
Tokyo,
Japan
|
-$639K |
| 5 |
Jane Street
New York
|
-$482K |
GNOM Hedge Fund Activity: Q1 2023 in Review
64 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q1 2023, worth a combined $138M — up 14% from $121M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of GNOM and 9 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 19 added.
The largest buyer was Northwestern Mutual Wealth Management, adding an estimated $10M. The largest seller was McGuire Investment Group, cutting an estimated $2.03M.
- 64 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q1 2023, down from 65 in Q4 2022.
- Funds reported $138M of Global X Genomics & Biotechnology ETF stock for Q1 2023, up 14% quarter-over-quarter.
- 9 funds opened new Global X Genomics & Biotechnology ETF positions in Q1 2023 and 10 closed out, a net change of -1 holder.
- The largest Global X Genomics & Biotechnology ETF buyer in Q1 2023 was Northwestern Mutual Wealth Management, an estimated $10M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q1 2023 was McGuire Investment Group, an estimated $2.03M sold.
Based on aggregated 13F filings for Q1 2023.